Sublingual immunotherapy: World Allergy Organization position paper 2013 update

Abstract

We have prepared this document, "Sublingual Immunotherapy: World Allergy Organization Position Paper 2013 Update", according to the evidence-based criteria, revising and updating chapters of the originally published paper, "Sublingual Immunotherapy: World Allergy Organization Position Paper 2009", available at http://www.waojournal.org. Namely, these comprise: "Mechanisms of sublingual immunotherapy;" "Clinical efficacy of sublingual immunotherapy" - reporting all the data of all controlled trials published after 2009; "Safety of sublingual immunotherapy" - with the recently published Grading System for adverse reactions; "Impact of sublingual immunotherapy on the natural history of respiratory allergy" - with the relevant evidences published since 2009; "Efficacy of SLIT in children" - with detailed analysis of all the studies; "Definition of SLIT patient selection" - reporting the criteria for eligibility to sublingual immunotherapy; "The future of immunotherapy in the community care setting"; "Methodology of clinical trials according to the current scientific and regulatory standards"; and "Guideline development: from evidence-based medicine to patients' views" - including the evolution of the methods to make clinical recommendations.Additionally, we have added new chapters to cover a few emerging crucial topics: "Practical aspects of schedules and dosages and counseling for adherence" - which is crucial in clinical practice for all treatments; "Perspectives and new approaches" - including recombinant allergens, adjuvants, modified allergens, and the concept of validity of the single products. Furthermore, "Raising public awareness about sublingual immunotherapy", as a need for our patients, and strategies to increase awareness of allergen immunotherapy (AIT) among patients, the medical community, all healthcare stakeholders, and public opinion, are also reported in detail.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 341

1. 1.

   Radulovic S Wilson D Calderon M Durham S Systematic reviews of sublingual immunotherapy (SLIT)Allergy2011 7740752

   Not in our library10.1111/j.1398-9995.2011.02583.x

2. 2.

   Calderon MA Penagos M Sheikh A Canonica GW Durham SR Sublingual immunotherapy for allergic conjunctivitis: cochrane systematic review and meta-analysisClin Exp Allergy2011 712631272

   Not in our library10.1111/j.1365-2222.2011.03835.x

3. 3.

   Didier A Worm M Horak F Sussman G de Beaumont O Le Gall M Melac M Malling HJ Sustained 3-year efficacy of pre- and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitisJ Allergy Clin Immunol2011 7559566

   Not in our library10.1016/j.jaci.2011.06.022

4. 4.

   Durham SR Emminger W Kapp A de Monchy JG Rak S Scadding GK Wurtzen PA Andersen JS Tholstrup B Riis B Dahl R SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trialJ Allergy Clin Immunol2012 7717725e715

   Not in our library10.1016/j.jaci.2011.12.973

5. 5.

   Akdis CA Akdis M Mechanisms of allergen-specific immunotherapyJ Allergy Clin Immunol2011 71827quiz 28-19

   Not in our library10.1016/j.jaci.2010.11.030

6. 6.

   Maggi E Vultaggio A Matucci A T-cell responses during allergen-specific immunotherapyCurr Opin Allergy Clin Immunol2012 716

   Not in our library10.1097/aci.0b013e32834ecc9a

7. 7.

   Scadding G Durham S Mechanisms of sublingual immunotherapyJ Asthma2009 7322334

   Not in our library10.1080/02770900902785729

8. 8.

   Scadding G Durham SR Mechanisms of sublingual immunotherapyImmunol Allergy Clin North Am2011 7191209viii

   Not in our library10.1016/j.iac.2011.02.005

9. 9.

   Canonica GW Bousquet J Casale T Lockey RF Baena-Cagnani CE Pawankar R Potter PC Bousquet PJ Cox LS Durham SR Nelson HS Passalacqua G Ryan DP Brozek JL Compalati E Dahl R Delgado L van Wijk RG Gower RG Ledford DK Filho NR Valovirta EJ Yusuf OM Zuberbier T Akhanda W Almarales RC Ansotegui I Bonifazi F Ceuppens J Chivato T Sub-lingual immunotherapy: World Allergy Organization position paper 2009Allergy2009 7Suppl 91159

   Not in our library10.1111/j.1398-9995.2009.02309.x

10. 10.

    Allam JP Duan Y Winter J Stojanovski G Fronhoffs F Wenghoefer M Bieber T Peng WM Novak N Tolerogenic T cells, Th1/Th17 cytokines and TLR2/TLR4 expressing dendritic cells predominate the microenvironment within distinct oral mucosal sitesAllergy2011 7532539

    Not in our library10.1111/j.1398-9995.2010.02510.x

11. 11.

    Allam JP Wurtzen PA Reinartz M Winter J Vrtala S Chen KW Valenta R Wenghoefer M Appel T Gros E Niederhagen B Bieber T Lund K Novak N Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing propertiesJ Allergy Clin Immunol2010 7638645e631

    Not in our library10.1016/j.jaci.2010.04.039

12. 12.

    Allam JP Stojanovski G Friedrichs N Peng W Bieber T Wenzel J Novak N Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?Allergy2008 7720727

    Not in our library10.1111/j.1398-9995.2007.01611.x

13. 13.

    Palomares O Ruckert B Jartti T Kucuksezer UC Puhakka T Gomez E Fahrner HB Speiser A Jung A Kwok WW Kalogjera L Akdis M Akdis CA Induction and maintenance of allergen-specific FOXP3+ Treg cells in human tonsils as potential first-line organs of oral toleranceJ Allergy Clin Immunol2012 7510520520 e511-519

    Not in our library10.1016/j.jaci.2011.09.031

14. 14.

    Kücüksezer UC Palomares O Rückert B Jartti T Puhakka T Nandy A Gemicioğlu B Fahrner HB Jung A Deniz G Akdis CA Akdis M Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral bloodJ Allergy Clin Immunol2013 7875885

    Not in our library10.1016/j.jaci.2012.10.051

15. 15.

    Scadding GW Shamji MH Jacobson MR Lee DI Wilson D Lima MT Pitkin L Pilette C Nouri-Aria K Durham SR Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cellsClin Exp Allergy2010 7598606

    Not in our library10.1111/j.1365-2222.2010.03462.x

16. 16.

    Pfaar O Barth C Jaschke C Hormann K Klimek L Sublingual allergen-specific immunotherapy adjuvanted with monophosphoryl lipid A: a phase I/IIa studyInt Arch Allergy Immunol2011 7336344

    Not in our library10.1159/000321826

17. 17.

    Piconi S Trabattoni D Rainone V Borgonovo L Passerini S Rizzardini G Frati F Iemoli E Clerici M Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4J Immunol2010 777237730

    Not in our library10.4049/jimmunol.1002465

18. 18.

    O’Hehir RE Gardner LM de Leon MP Hales BJ Biondo M Douglass JA Rolland JM Sandrini A House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cellsAm J Respir Crit Care Med2009 7936947

    Not in our library10.1164/rccm.200905-0686oc

19. 19.

    Scadding GW Calderon MA Bellido V Koed GK Nielsen NC Lund K Togias A Phippard D Turka LA Hansel TT Durham SR Wurtzen PA Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomesJ Immunol Methods2012 72532

    Not in our library10.1016/j.jim.2012.06.013

20. 20.

    Swamy RS Reshamwala N Hunter T Vissamsetti S Santos CB Baroody FM Hwang PH Hoyte EG Garcia MA Nadeau KC Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapyJ Allergy Clin Immunol2012 7215224e217

    Not in our library10.1016/j.jaci.2012.04.021

21. 21.

    Van Overtvelt L Baron-Bodo V Horiot S Moussu H Ricarte C Horak F Zieglmayer P Zieglmayer R Montagut A Galvain S de Beaumont O Le Gall M Moingeon P Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacyAllergy2011 715301537

    Not in our library10.1111/j.1398-9995.2011.02696.x

22. 22.

    Bohle B Kinaciyan T Gerstmayr M Radakovics A Jahn-Schmid B Ebner C Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviationJ Allergy Clin Immunol2007 7707713

    Not in our library10.1016/j.jaci.2007.06.013

23. 23.

    Fujimura T Yonekura S Taniguchi Y Horiguchi S Saito A Yasueda H Nakayama T Takemori T Taniguchi M Sakaguchi M Okamoto Y The induced regulatory T cell level, defined as the proportion of IL-10(+)Foxp3(+) cells among CD25(+)CD4(+) leukocytes, is a potential therapeutic biomarker for sublingual immunotherapy: a preliminary reportInt Arch Allergy Immunol2010 7378387

    Not in our library10.1159/000316349

24. 24.

    Keles S Karakoc-Aydiner E Ozen A Izgi AG Tevetoglu A Akkoc T Bahceciler NN Barlan I A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routesJ Allergy Clin Immunol2011 7808815e807

    Not in our library10.1016/j.jaci.2011.04.033

25. 25.

    Nieminen K Valovirta E Savolainen J Clinical outcome and IL-17, IL-23, IL-27 and FOXP3 expression in peripheral blood mononuclear cells of pollen-allergic children during sublingual immunotherapyPediatr Allergy Immunol2010 7e174e184

    Not in our library10.1111/j.1399-3038.2009.00920.x

26. 26.

    Wei W Liu Y Wang Y Zhao Y He J Li X Shen K Induction of CD4 + CD25 + Foxp3 + IL-10+ T cells in HDM-allergic asthmatic children with or without SITInt Arch Allergy Immunol2010 71926

    Not in our library10.1159/000301575

27. 27.

    Eifan AO Akkoc T Yildiz A Keles S Ozdemir C Bahceciler NN Barlan IB Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trialClin Exp Allergy2010 7922932

    Not in our library10.1111/j.1365-2222.2009.03448.x

28. 28.

    Bonvalet M Moussu H Wambre E Ricarte C Horiot S Rimaniol AC Kwok WW Horak F de Beaumont O Baron-Bodo V Moingeon P Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy (ClinicalTrials.gov NCT00619827)Clin Exp Allergy2012 717451755

    Not in our library10.1111/cea.12015

29. 29.

    Bonvalet M Wambre E Moussu H Horiot S Kwok WW Louise A Ebo D Hoarau C Van Overtvelt L Baron-Bodo V Moingeon P Comparison between major histocompatibility complex class II tetramer staining and surface expression of activation markers for the detection of allergen-specific CD4(+) T cellsClin Exp Allergy2011 7821829

    Not in our library10.1111/j.1365-2222.2011.03708.x

30. 30.

    Campbell JD Buchmann P Kesting S Cunningham CR Coffman RL Hessel EM Allergen-specific T cell responses to immunotherapy monitored by CD154 and intracellular cytokine expressionClin Exp Allergy2010 710251035

    Not in our library10.1111/j.1365-2222.2010.03505.x

31. 31.

    Zimmer A Bouley J Le Mignon M Pliquet E Horiot S Turfkruyer M Baron-Bodo V Horak F Nony E Louise A Moussu H Mascarell L Moingeon P A regulatory dendritic cell signature correlates with the clinical efficacy of allergen-specific sublingual immunotherapyJ Allergy Clin Immunol2012 710201030

    Not in our library10.1016/j.jaci.2012.02.014

32. 32.

    Di Lorenzo G Mansueto P Pacor ML Rizzo M Castello F Martinelli N Ditta V Lo Bianco C Leto-Barone MS D’Alcamo A Di Fede G Rini GB Ditto AM Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapyJ Allergy Clin Immunol2009 7110311101110 e1101-1104

    Not in our library10.1016/j.jaci.2009.02.012

33. 33.

    Gehlhar K Schlaak M Becker W Bufe A Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcomeClin Exp Allergy1999 7497506

    Not in our library10.1046/j.1365-2222.1999.00525.x

34. 34.

    Asero R Component-resolved diagnosis-assisted prescription of allergen-specific immunotherapy: a practical guideEur Ann Allergy Clin Immunol2012 7183187

    Not in our library

35. 35.

    Wolthers OD Component-resolved diagnosis in pediatricsISRN Pediatr2012 7806920

    Not in our library10.5402/2012/806920

36. 36.

    Würtzen PA Lund G Lund K Arvidsson M Rak S Ipsen H A double-blind placebo-controlled birch allergy vaccination study II: correlation between inhibition of IgE binding, histamine release and facilitated allergen presentationClin Exp Allergy2008 712901301

    Not in our library10.1111/j.1365-2222.2008.03020.x

37. 37.

    Shamji MH Wilcock LK Wachholz PA Dearman RJ Kimber I Wurtzen PA Larche M Durham SR Francis JN The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responsesJ Immunol Methods2006 77179

    Not in our library10.1016/j.jim.2006.09.004

38. 38.

    Shamji MH Ljorring C Francis JN Calderon MA Larche M Kimber I Frew AJ Ipsen H Lund K Wurtzen PA Durham SR Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapyAllergy2012 7217226

    Not in our library10.1111/j.1398-9995.2011.02745.x

39. 39.

    Pastorello EA Incorvaia C Ortolani C Bonini S Canonica GW Romagnani S Tursi A Zanussi C Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergensJ Allergy Clin Immunol1995 7580587

    Not in our library10.1016/s0091-6749(95)70255-5

40. 40.

    Blaiss M Maloney J Nolte H Gawchik S Yao R Skoner DP Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescentsJ Allergy Clin Immunol2011 7647171 e61-64

    Not in our library10.1016/j.jaci.2010.11.034

Cited by papers we hold 5

• Modulating Th2 Cell Immunity for the Treatment of Asthma · 2021
  No notice
• Research Progress in Atopic March · 2020
  No notice
• Allergic rhinitis · 2018
  No notice
• Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens · 2015
  No notice
• A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics · 2013
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.